比较仅用HCG触发与双重触发在孕激素预处理卵巢刺激方案中促进最终卵母细胞成熟的差异
本回顾性队列研究纳入1066名40岁以下卵巢储备正常的IVF/ICSI患者,比较PPOS方案中仅HCG触发与GnRHa联合HCG双重触发的临床结局。双重触发组获卵数更多,但两组累积活产率无显著差异,多因素分析显示触发方式与累积活产率无关,提示双重触发可能无额外获益且不推荐常规使用。
要点
- 双重触发组获卵数多于仅HCG触发组,但累积活产率无显著差异。
- 多因素分析显示触发方式与累积活产率无关联。
- 作者认为双重触发可能无额外获益,不推荐在PPOS方案中常规使用。
核心结论
- 与仅HCG触发组相比,双重触发组获得可比的胚胎学和临床结局,尽管获卵数更多,提示双重触发可能无额外获益,不推荐在PPOS方案普通人群中常规使用。
研究设计与样本
- 回顾性队列研究,纳入40岁以下卵巢储备正常、采用PPOS方案行IVF/ICSI的女性,共1066人,仅HCG触发组565人,双重触发组501人。
主要发现
- 双重触发组获卵数12.56 ± 7.12 vs 仅HCG触发组11.62 ± 6.02(P = 0.020)。
- 双原核胚胎数7.12 ± 4.90 vs 6.76 ± 4.45(P = 0.208),优质胚胎数4.01 ± 3.70 vs 3.96 ± 3.32(P = 0.815),均无显著差异。
- 一个完整周期的累积活产率40.72% vs 43.72%(P = 0.354),无显著差异。
- 多因素logistic分析显示触发方式与累积活产率无关联(OR 0.763,95%CI 0.578-1.005,P = 0.055)。
临床怎么用
- 作者认为双重触发可能无额外获益,不推荐在PPOS方案普通人群中常规使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is there any difference in clinical outcomes between a human chorionic gonadotrophin (HCG)-only trigger and a dual trigger combining gonadotrophin-releasing hormone agonist (GnRHa) and HCG in a progestin-primed ovarian stimulation (PPOS) protocol? DESIGN: This retrospective cohort study included women younger than 40 years old with a normal ovarian reserve who underwent IVF/intracytoplasmic sperm injection treatment with a PPOS protocol. Participants were allocated to two groups according to the triggering medicines. The clinical outcomes were compared, with cumulative live birth rate (CLBR) being the primary outcome. RESULTS: In total, 1066 women were included, 565 in the HCG-only group and 501 in the dual trigger group. Demographic parameters were comparable between the groups. Fewer oocytes were retrieved in the HCG-only trigger group (dual trigger 12.56 ± 7.12 versus HCG-only trigger 11.62 ± 6.02, P = 0.020). No significant difference was observed in the numbers of two-pronuclear embryos (7.12 ± 4.90 versus 6.76 ± 4.45, P = 0.208) and high-quality embryos (4.01 ± 3.70 versus 3.96 ± 3.32, P = 0.815). The CLBR after one complete cycle was also similar (40.72% versus 43.72%, P = 0.354). Multivariate logistic analysis confirmed that the trigger method had no association with CLBR (odds ratio [OR] 0.763, 95% confidence interval [CI] 0.578-1.005, P = 0.055) in the PPOS-treated patients. CONCLUSIONS: Compared with the HCG-only trigger group, comparable embryological and clinical outcomes were achieved, although more oocytes were retrieved in the dual trigger group. This suggests that there may be no extra benefit from dual triggering, and that it should not be recommended for routine use in the general population undergoing PPOS protocols.
引用
- Li Q, Li X, Li T, et al. Comparison of an HCG-only trigger versus dual trigger for final oocyte maturation in a progestin-primed ovarian stimulation protocol. Reprod Biomed Online. 2022. PMID: 36207251. doi:10.1016/j.rbmo.2022.08.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。